Beckman Coulter, Inc.

Beckman Coulter, Inc. is a global manufacturer of biomedical laboratory instruments and a subsidiary of Danaher Corporation (NYSE: DHR). Founded in 1935 as National Technical Laboratories by Dr. Arnold O. Beckman, the company is headquartered in Brea, California. Since being acquired by Danaher in 2011, Beckman Coulter operates through two main divisions: Beckman Coulter Diagnostics and Beckman Coulter Life Sciences. The company employs over 12,000 people worldwide.

The company develops, manufactures, and markets products that simplify and automate complex biomedical testing for hospitals, laboratories, and research institutions. Its Diagnostics division provides instruments and reagents for clinical chemistry, immunoassay, hematology, urinalysis, and microbiology. The Life Sciences division offers a range of instruments for scientific research, including centrifuges, cell counters, flow cytometers, and genomic solutions. These tools are used in various phases of disease research, drug discovery, and medical diagnostics.

Based on its litigation history, Beckman Coulter is an operating company that both asserts its own patents and defends itself in patent disputes. The provided data shows an even split with one case as a plaintiff and one as a defendant, indicating a two-way litigant posture against a direct competitor rather than activity typical of a non-practicing entity (NPE).

The company's tracked patent cases involve competitor Cytek Biosciences, Inc. Beckman Coulter is the plaintiff in a patent infringement suit filed in the U.S. District Court for the District of Delaware. In a related matter, Cytek is the petitioner in a proceeding against Beckman Coulter before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board, a common defensive tactic in response to an infringement lawsuit. The dispute centers on flow cytometer technology, a key product area for both companies.